IRAK4 Antikörper (N-Term)
Kurzübersicht für IRAK4 Antikörper (N-Term) (ABIN2290936)
Target
Alle IRAK4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 32-60, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- IRAK4, NT (IRAK4, Interleukin-1 receptor-associated kinase 4, Renal carcinoma antigen NY-REN-64)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- IRAK4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 32-60 amino acids from the N-terminal region of human IRAK4.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- IRAK4 (Interleukin-1 Receptor-Associated Kinase 4 (IRAK4))
-
Andere Bezeichnung
- IRAK4
-
NCBI Accession
- NP_001107654, NP_057207
-
UniProt
- Q9NWZ3
-
Pathways
- NF-kappaB Signalweg, TLR Signalweg, Activation of Innate immune Response, Toll-Like Receptors Cascades
Target
-